Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?

被引：106

作者：

Avet-Loiseau, Herve ^{[1
,2
]}

Malard, Florent ^{[2
]}

Campion, Loic ^{[3
]}

Magrangeas, Florence ^{[2
]}

Sebban, Catherine ^{[4
]}

Lioure, Bruno ^{[5
]}

Decaux, Olivier ^{[6
]}

Lamy, Thierry ^{[7
]}

Legros, Laurence ^{[8
]}

Fuzibet, Jean-Gabriel ^{[9
]}

Michallet, Mauricette ^{[10
]}

Corront, Bernadette ^{[11
]}

Lenain, Pascal ^{[12
]}

Hulin, Cyrille ^{[13
]}

Mathiot, Claire ^{[14
]}

Attal, Michel ^{[15
]}

Facon, Thierry ^{[16
]}

Harousseau, Jean-Luc ^{[17
]}

Minvielle, Stephane ^{[2
]}

Moreau, Philippe ^{[18
]}

机构：

[1] Univ Hosp, Hematol Lab, Inst Biol, F-44093 Nantes, France

[2] INSERM, U892, Nantes, France

[3] Ctr Rene Gauducheau, Dept Stat, F-44035 Nantes, France

[4] Ctr Leon Berard, Dept Hematol, F-69373 Lyon, France

[5] Univ Hosp, Dept Hematol, Strasbourg, France

[6] Univ Hosp, Dept Internal Med, Rennes, France

[7] Univ Hosp, Dept Hematol, Rennes, France

[8] Univ Hosp, Dept Hematol, Nice, France

[9] Univ Hosp, Dept Internal Med, Nice, France

[10] Univ Hosp, Dept Hematol, Lyon, France

[11] Univ Hosp, Dept Hematol, Annecy, France

[12] Ctr Francois Baclesse, Dept Hematol, Rouen, France

[13] Univ Hosp, Dept Hematol, Nancy, France

[14] Inst Curie, Hematol Lab, Paris, France

[15] Univ Hosp, Dept Hematol, Toulouse, France

[16] Univ Hosp, Dept Hematol, Lille, France

[17] Ctr Rene Gauducheau, Dept Hematol, F-44035 Nantes, France

[18] Univ Hosp, Dept Hematol, Nantes, France

来源：

BLOOD | 2011年 / 117卷 / 06期

关键词：

STEM-CELL TRANSPLANTATION; C-MAF; MAINTENANCE; THALIDOMIDE; EXPRESSION; SURVIVAL; THERAPY; TRIAL; GENE;

D O I：

10.1182/blood-2010-07-295105

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Many trials in myeloma are stratified on cytogenetic abnormalities. Among them, the most commonly chosen are the t(4;14), the del(17p), and the t(14;16). If data are well established for t(4;14) and del(17p), very few data support the use of t(14;16). To address this issue, we retro-spectively analyzed 1003 patients with newly diagnosed myeloma for this abnormality. We identified 32 patients with the t(14;16). Compared with patients lacking the t(14;16), we did not observe any difference in overall survival (P = .28). Moreover, in multivariate analyses, the t(14;16) was not prognostic (P = .39). In conclusion, our data do not support the use of t(14;16)-specific probes in the diagnostic panels of multiple myeloma. (Blood. 2011; 117(6): 2009-2011)

引用

页码：2009 / 2011

页数：3

共 50 条

[31] THE CLINICAL IMPACT OF CHROMOSOMAL TRANSLOCATION T(14;16)(Q32; Q23) IN PATIENTS WITH MULTIPLE MYELOMA
Pavlistova, L.
Berkova, A.
Zemanova, Z.
Svobodova, K.
Izakova, S.
Ransdorfova, S.
Spicka, I.
Straub, J.
Michalova, K.
HAEMATOLOGICA, 2017, 102 : 772 - 772
[32] The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma
Rasche, Leo
Angtuaco, Edgardo J.
Alpe, Terri L.
Gershner, Grant H.
McDonald, James E.
Samant, Rohan S.
Kumar, Manoj
Van Hemert, Rudy
Epstein, Joshua
Deshpande, Shayu
Tytarenko, Ruslana
Yaccoby, Shmuel
Hillengass, Jens
Thanendrarajan, Sharmilan
Schinke, Carolina
van Rhee, Frits
Zangari, Maurizio
Walker, Brian A.
Barlogie, Bart
Morgan, Gareth J.
Davies, Faith E.
Weinhold, Niels
BLOOD, 2018, 132 (01) : 59 - 66
[33] A Gene Expression Based Proliferation Index as Independent Prognostic Factor in Multiple Myeloma
Hose, Dipk
Reme, Thierry
Hielscher, Thomas
Moreaux, Jerome
Meissner, Tobias
Seckinger, Anja
Benner, Axel
Hundemer, Michael
Shaughnessy, John, Jr.
Barlogie, Bart
Hillengass, Jens
Bertsch, Uta
Jauch, Anna
Rossi, Jean Francois
Moehler, Thomas
Klein, Bernard
Goldschmidt, Hartmut
BLOOD, 2008, 112 (11) : 589 - 589
[34] The Translocation t(4;14) Can Be Present Only in Minor Subclones in Multiple Myeloma
Hebraud, Benjamin
Caillot, Denis
Corre, Jill
Marit, Gerald
Hulin, Cyrille
Leleu, Xavier
Lode, Laurence
Wetterwald, Marc
Dib, Mamoun
Rodon, Philippe
Voillat, Laurent
Royer, Bruno
Voog, Eric
Fitoussi, Olivier
Stoppa, Anne-Marie
Garderet, Laurent
Kolb, Brigitte
Maigre, Michel
Boullanger, Nadine
Allangba, Olivier
Karlin, Lionel
Daguindau, Nicolas
Legros, Laurence
Sohn, Claudine
Joubert, Marie-Veronique
Lenain, Pascal
Facon, Thierry
Attal, Michel
Moreau, Philippe
Avet-Loiseau, Herve
CLINICAL CANCER RESEARCH, 2013, 19 (17) : 4634 - 4637
[35] The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma
Paner, Agne
Patel, Pritesh
Dhakal, Binod
BLOOD REVIEWS, 2020, 41
[36] Identification of a novel t(7;14) translocation in multiple myeloma resulting in overexpression of EGFR
Walker, Brian A.
Wardell, Christopher P.
Ross, Fiona M.
Morgan, Gareth J.
GENES CHROMOSOMES & CANCER, 2013, 52 (09): : 817 - 822
[37] Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?
Leiba, Merav
Duek, Adrian
Amariglio, Ninette
Avigdor, Abraham
Benyamini, Noam
Hardan, Izhar
Zilbershats, Itay
Ganzel, Chezi
Shevetz, Olga
Novikov, Ilya
Cohen, Yossi
Ishoev, Galina
Rozic, Gabriela
Nagler, Arnon
Trakhtenbrot, Luba
GENES CHROMOSOMES & CANCER, 2016, 55 (09): : 710 - 718
[38] Bone involvement in multiple myeloma patients carrying the T(4;14) chromosomal translocation
Perrone, G.
Tosi, P.
Zamagni, E.
Tacchetti, P.
Ceccolini, M.
Brioli, A.
Tura, S.
Baccarani, M.
Cavo, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 137 - 137
[39] The incidence of translocation t(11;14) among patients with multiple myeloma in a single clinic
Jew, Scott
Goldwater, Marissa-Skye
Bujarski, Sean
Regidor, Bernard
Emamy-Sadr, Marsiye
Swift, Regina
Eades, Benjamin
Said, Jonathan
Berenson, James R.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 161 (01) : 16 - 23
[40] Prognostic Impact of t(11;14) in Newly Diagnosed Patients With Multiple Myeloma
Ntanasis-Stathopoulos, Ioannis
Terpos, Evangelos
Briasoulis, Alexandros
Malandrakis, Panagiotis
Fotiou, Despina
Migkou, Magdalini
Spiliopoulou, Vasiliki
Theodorakakou, Foteini
Filippatos, Charalampos
Roussou, Maria
Kanellias, Nikolaos
Eleftherakis-Papaiakovou, Evangelos
Kastritis, Efstathios
Dimopoulos, Meletios
Gavriatopoulou, Maria
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S238 - S239

← 1 2 3 4 5 →